Carbohydrate-binding module (CBM)

Carbohydrate-binding modules (CBMs) are non-catalytic protein domains found within carbohydrate-active enzymes, such as glycoside hydrolases and polysaccharide lyases. Their principal function is to mediate the binding of the enzyme to specific carbohydrate substrates—such as cellulose, xylan, or chitin—thereby increasing the enzyme's catalytic efficiency against insoluble or complex carbohydrates[1][2][4][5]. CBMs are highly diverse, classified into more than 80 families based on amino acid sequence and binding specificity, each showing preference for certain types of polysaccharides or glycan structures[5]. While CBMs are critical for localization and substrate targeting in enzymes, they do not have intrinsic receptor or catalytic activity and are generally not considered standalone drug targets or disease biomarkers. However, CBMs are valuable in biotechnology and as models for protein-carbohydrate interaction studies. Some lectins and other carbohydrate-binding proteins share structural similarities with CBMs, but as a class, CBMs are defined as accessory modules attached to enzymes rather than standalone receptors or enzymes[2][4][5]. It's important to note that "Carbohydrate-binding" (and by extension, CBMs as a general class) is considered too vague and not a unique molecular target for therapeutic purposes. It describes a functional property across a wide range of diverse domains and proteins (including lectins), rather than a specific, well-defined gene, protein, or therapeutic target. Therefore, there is no canonical abbreviation or direct therapeutic role for "generic" carbohydrate-binding activity or CBMs as a whole. More specific targets would involve individual CBM families (e.g., 'Carbohydrate-binding module family 1') or named lectins.

Other names

Carbohydrate-binding domainCellulose-binding domain (outdated)Sugar-binding module